Fusion Antibodies Plc (FAB.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 03-2018 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 4,491 |
| Inventories | 82 |
| Other current assets | 933 |
| TOTAL | $5,506 |
| Non-Current Assets | |
| PPE Net | 547 |
| Other Non-Current Assets | 1,156 |
| TOTAL | $1,703 |
| Total Assets | $7,209 |
| Liabilities | |
| Current Liabilities | |
| Accounts payable and accrued liabilities | 281 |
| TOTAL | $570 |
| Non-Current Liabilities | |
| Other Non-Current Liabilities | 64 |
| TOTAL | $64 |
| Total Liabilities | $634 |
| Shareholders' Equity | |
| Common Shares | 884 |
| Retained earnings | 819 |
| TOTAL | $6,575 |
| Total Liabilities And Equity | $7,209 |